About this FactMed analysis covering adverse side effect reports of L-CARNITINE patients who developed HALLUCINATION, AUDITORY.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking L-CARNITINE reported HALLUCINATION, AUDITORY to the FDA. A total of 333 L-CARNITINE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between L-CARNITINE and HALLUCINATION, AUDITORY. In doing so, we compare L-CARNITINE with other drugs that cause HALLUCINATION, AUDITORY, to help you evaluate whether or not L-CARNITINE causes HALLUCINATION, AUDITORY. Likewise, this page shows the most highly-reported side effects of L-CARNITINE, so you can see if HALLUCINATION, AUDITORY ranks among L-CARNITINE's most well-known side effects.
Summary Statistics
Reports of L-CARNITINE causing HALLUCINATION, AUDITORY: 1
Reports of any side effect of L-CARNITINE : 333
Percentage of L-CARNITINE patients where HALLUCINATION, AUDITORY is a reported side effect: 0.3003%

FDA reports of any drug causing HALLUCINATION, AUDITORY : 5771
Average percentage for all medicated patients where HALLUCINATION, AUDITORY is reported as a complication: 0.0362%

Physician opinion on L-CARNITINE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing L-CARNITINE:
DRUG USE FOR UNKNOWN INDICATION ( 24 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 24 patients )
VITAMIN SUPPLEMENTATION ( 6 patients )
SUPPLEMENTATION THERAPY ( 4 patients )
HEPATITIS ( 4 patients )
ILL-DEFINED DISORDER ( 3 patients )
WEIGHT CONTROL ( 3 patients )
MINERAL SUPPLEMENTATION ( 2 patients )
MUSCULAR DYSTROPHY ( 2 patients )
NUTRITIONAL SUPPORT ( 2 patients )
ASPARTATE AMINOTRANSFERASE INCREASED ( 1 patients )
MALABSORPTION ( 1 patients )
ATRIAL FIBRILLATION ( 1 patients )
MEDIUM-CHAIN ACETYL-COENZYME A DEHYDROGENASE DEFICIENCY ( 1 patients )
CARDIAC DISORDER ( 1 patients )
MITRAL VALVE PROLAPSE ( 1 patients )
CARNITINE DEFICIENCY ( 1 patients )
MUSCLE FATIGUE ( 1 patients )
CONVULSION ( 1 patients )
MUSCULAR WEAKNESS ( 1 patients )
PARAESTHESIA ( 1 patients )
FATIGUE ( 1 patients )
HYPERAMMONAEMIC ENCEPHALOPATHY ( 1 patients )
ACIDOSIS ( 1 patients )
INCREASED APPETITE ( 1 patients )
ASTHENIA ( 1 patients )
MEDICAL DIET ( 1 patients )
BLOOD LACTATE DEHYDROGENASE ABNORMAL ( 1 patients )
CARNITINE DECREASED ( 1 patients )
MUSCLE ATROPHY ( 1 patients )
CHRONIC FATIGUE SYNDROME ( 1 patients )
CROHN'S DISEASE ( 1 patients )
EPILEPSY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with HALLUCINATION, AUDITORY:

SEROQUEL (1487 patients)
RISPERDAL (557 patients)
ZYPREXA (444 patients)
CHANTIX (416 patients)
CLOZARIL (377 patients)
RISPERIDONE (346 patients)
PAXIL (338 patients)
ABILIFY (288 patients)
ZOLOFT (262 patients)
HALDOL (257 patients)
LORAZEPAM (218 patients)
CLOZAPINE (212 patients)
GEODON (203 patients)
LEXAPRO (186 patients)
CYMBALTA (183 patients)
KLONOPIN (180 patients)
PROZAC (177 patients)
ASPIRIN (174 patients)
DEPAKOTE (173 patients)
EFFEXOR (173 patients)
ATIVAN (172 patients)
SEROQUEL XR (171 patients)
XANAX (169 patients)
DIAZEPAM (165 patients)
CLONAZEPAM (161 patients)
OLANZAPINE (161 patients)
TOPROL-XL (159 patients)
MIRTAZAPINE (157 patients)
LAMICTAL (147 patients)
NEURONTIN (146 patients)
AMBIEN (145 patients)
WELLBUTRIN (143 patients)
COGENTIN (140 patients)
RISPERDAL CONSTA (139 patients)
CELEXA (138 patients)
ARIPIPRAZOLE (136 patients)
SIMVASTATIN (135 patients)
HALOPERIDOL (132 patients)
CITALOPRAM HYDROBROMIDE (130 patients)
TRAZODONE HCL (129 patients)
TEGRETOL (127 patients)
CONCERTA (127 patients)
LIPITOR (127 patients)
LITHIUM CARBONATE (127 patients)
NEXIUM (123 patients)
SUBOXONE (121 patients)
STRATTERA (119 patients)
PRILOSEC (110 patients)
FLUOXETINE (108 patients)
PAROXETINE HCL (108 patients)
METFORMIN HCL (106 patients)
LYRICA (103 patients)
LISINOPRIL (101 patients)
RITALIN (101 patients)
ALBUTEROL (99 patients)
VALPROATE SODIUM (99 patients)
TOPIRAMATE (98 patients)
ZOCOR (98 patients)
INVEGA SUSTENNA (97 patients)
ATENOLOL (96 patients)
OMEPRAZOLE (95 patients)
TRAMADOL HCL (95 patients)
IBUPROFEN (90 patients)
HYDROCHLOROTHIAZIDE (90 patients)
SINGULAIR (89 patients)
QUETIAPINE (89 patients)
SYNTHROID (89 patients)
VISTARIL (86 patients)
EFFEXOR XR (86 patients)
TOPAMAX (85 patients)
LASIX (84 patients)
POTASSIUM CHLORIDE (83 patients)
OXYCONTIN (83 patients)
INVEGA (83 patients)
PREVACID (83 patients)
SERTRALINE HYDROCHLORIDE (81 patients)
ALL OTHER THERAPEUTIC PRODUCTS (81 patients)
KEPPRA (78 patients)
VFEND (77 patients)
TAMIFLU (77 patients)
BETASERON (76 patients)
ALPRAZOLAM (75 patients)
VIOXX (74 patients)
LEVOTHYROXINE SODIUM (73 patients)
RELENZA (71 patients)
VALIUM (70 patients)
PREDNISONE (70 patients)
HYDROXYZINE (67 patients)
MOTRIN (67 patients)
FOSAMAX (67 patients)
CLONIDINE (67 patients)
BENADRYL (66 patients)
GABAPENTIN (66 patients)
NITROGLYCERIN (65 patients)
NICOTINE (65 patients)
ACETAMINOPHEN (64 patients)
VICODIN (64 patients)
PEG-INTRON (62 patients)
CARBAMAZEPINE (61 patients)
QUETIAPINE FUMARATE (61 patients)
AMISULPRIDE (61 patients)
PERCOCET (60 patients)
TEMAZEPAM (59 patients)
REMERON (59 patients)
LAMOTRIGINE (59 patients)
NORVASC (58 patients)
MORPHINE (58 patients)
FOLIC ACID (58 patients)
OXYCODONE HCL (57 patients)
ACTONEL (56 patients)
DARVOCET (56 patients)
LITHIUM (55 patients)
AMLODIPINE (54 patients)
LANSOPRAZOLE (53 patients)
COFFEE (53 patients)
DURAGESIC-100 (53 patients)
CELEBREX (53 patients)
AVONEX (52 patients)
ZANAFLEX (51 patients)
BECLAMIDE (50 patients)
ULTRAM (50 patients)
CITALOPRAM (50 patients)
COUMADIN (50 patients)
METFORMIN (49 patients)
CORTISONE (49 patients)
ZONISAMIDE (49 patients)
MYCOPHENOLATE MOFETIL (CELLCEPT) (49 patients)
VALPROIC ACID (48 patients)
PRISTIQ (48 patients)
ZANTAC (48 patients)
WELLBUTRIN SR (47 patients)
RIBAVIRIN (47 patients)
PLAVIX (47 patients)
PRIALT (46 patients)
TRILEPTAL (46 patients)
ZOPICLONE (45 patients)
PREDNISOLONE (45 patients)
AKINETON (45 patients)
VENLAFAXINE HCL (45 patients)
ELAVIL (44 patients)
FUROSEMIDE (44 patients)
NAMENDA (44 patients)
MULTI-VITAMIN (43 patients)
BACLOFEN (43 patients)
FLEXERIL (43 patients)
PROTONIX (43 patients)
REMICADE (41 patients)
INSULIN (41 patients)
LUNESTA (41 patients)
FLUCONAZOLE (41 patients)
CIPROFLOXACIN (41 patients)
TRAZODONE (40 patients)
ACCUTANE (40 patients)
RAMIPRIL (40 patients)
ICL670A ICL+DISTAB (40 patients)
OXYCODONE (40 patients)
NORETHINDRONE (39 patients)
RANITIDINE (39 patients)
METHOTREXATE (39 patients)
SERTRALINE HCL (39 patients)
PROPRANOLOL (39 patients)
ARICEPT (38 patients)
ZOLPIDEM (38 patients)
HYDROCODONE (37 patients)
MIRAPEX (37 patients)
ALLOPURINOL (37 patients)
ENBREL (37 patients)
PEGASYS (37 patients)
PROMETHAZINE (36 patients)
TRAMADOL HYDROCHLORIDE (36 patients)
MAGNESIUM OXIDE (36 patients)
REBIF (36 patients)
CELLCEPT (35 patients)
NAVANE (35 patients)
ARTANE (35 patients)
ESCITALOPRAM (35 patients)
VYVANSE (35 patients)
GLYBURIDE (35 patients)
BUSPAR (35 patients)
BENZTROPINE MESYLATE (34 patients)
VALTREX (34 patients)
BACTRIM (34 patients)
PALIPERIDONE (34 patients)
TYLENOL (CAPLET) (34 patients)
WELLBUTRIN XL (34 patients)
LEPONEX (33 patients)
AMOXICILLIN (33 patients)
METOPROLOL (33 patients)
CHAMPIX (33 patients)
BUPROPION HCL (32 patients)
REQUIP (32 patients)
PAROXETINE HYDROCHLORIDE (32 patients)
HALCION (32 patients)
AVANDIA (32 patients)
DEPAS (32 patients)
SULPIRIDE (31 patients)
COLACE (31 patients)
SKELAXIN (31 patients)
CEPHALEXIN (31 patients)
AMITRIPTYLINE HCL (30 patients)
SERZONE (30 patients)
FERROUS SULFATE TAB (30 patients)
PROVIGIL (30 patients)
VITAMIN B-12 (30 patients)
METRONIDAZOLE (30 patients)
GLUCOPHAGE (30 patients)
NEORAL (30 patients)
METOPROLOL TARTRATE (30 patients)
METHADONE HCL (30 patients)
NAPROXEN (30 patients)
Most common side effects for patients taking L-CARNITINE:
DEHYDRATION (21 patients)
ARTHRALGIA (17 patients)
NAUSEA (17 patients)
FATIGUE (17 patients)
CONVULSION (16 patients)
ABDOMINAL PAIN (15 patients)
DYSPNOEA (15 patients)
DIZZINESS (15 patients)
DRUG INEFFECTIVE (15 patients)
ANAEMIA (14 patients)
ELECTROCARDIOGRAM QT PROLONGED (14 patients)
LETHARGY (13 patients)
EXTRASYSTOLES (13 patients)
GASTROENTERITIS (13 patients)
CONFUSIONAL STATE (13 patients)
PAIN (12 patients)
BACK PAIN (12 patients)
GAIT DISTURBANCE (12 patients)
MYOCARDIAL INFARCTION (12 patients)
HAEMOGLOBIN DECREASED (11 patients)
WEIGHT DECREASED (11 patients)
INJURY (11 patients)
CEREBRAL ISCHAEMIA (11 patients)
OEDEMA PERIPHERAL (11 patients)
HEADACHE (11 patients)
DEATH (11 patients)
INSOMNIA (11 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (11 patients)
SOMNOLENCE (10 patients)
ASTHENIA (10 patients)
HYPOTENSION (10 patients)
URINARY TRACT INFECTION (10 patients)
VOMITING (10 patients)
SPINAL COMPRESSION FRACTURE (9 patients)
ANGINA PECTORIS (9 patients)
MYOCARDIAL ISCHAEMIA (9 patients)
PAIN IN EXTREMITY (9 patients)
CHRONIC MYELOID LEUKAEMIA (9 patients)
WEIGHT INCREASED (8 patients)
HYPERTENSION (8 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (8 patients)
TROPONIN I INCREASED (8 patients)
CEREBRAL HAEMORRHAGE (8 patients)
PNEUMONIA (8 patients)
DECREASED APPETITE (8 patients)
DIARRHOEA (8 patients)
DUODENAL ULCER (8 patients)
ALANINE AMINOTRANSFERASE INCREASED (7 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (7 patients)
LEUKOPENIA (7 patients)
TRANSAMINASES INCREASED (7 patients)
INTESTINAL OBSTRUCTION (7 patients)
CHEST PAIN (7 patients)
CONSTIPATION (7 patients)
RENAL FAILURE (7 patients)
INFLAMMATION (7 patients)
AGITATION (6 patients)
AMMONIA INCREASED (6 patients)
PERIPHERAL ISCHAEMIA (6 patients)
ASPIRATION (6 patients)
ATRIAL FIBRILLATION (6 patients)
LYMPHOCYTOSIS (6 patients)
MUSCULAR WEAKNESS (6 patients)
MYALGIA (6 patients)
RENAL FAILURE ACUTE (6 patients)
HYPOXIA (6 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (6 patients)
BURNING SENSATION (6 patients)
CARDIAC FAILURE (6 patients)
OSTEONECROSIS (6 patients)
PYREXIA (6 patients)
RETICULOCYTE COUNT DECREASED (6 patients)
DEEP VEIN THROMBOSIS (6 patients)
THROMBOCYTOPENIA (6 patients)
DRUG INTERACTION (6 patients)
TROPONIN INCREASED (6 patients)
ABDOMINAL DISCOMFORT (5 patients)
ABDOMINAL DISTENSION (5 patients)
MALAISE (5 patients)
THERAPEUTIC RESPONSE DECREASED (5 patients)
GASTRITIS (5 patients)
PLATELET COUNT DECREASED (5 patients)
VISION BLURRED (5 patients)
BUNDLE BRANCH BLOCK RIGHT (5 patients)
MENTAL DISORDER (5 patients)
MENTAL IMPAIRMENT (5 patients)
ELECTROCARDIOGRAM ST SEGMENT ABNORMAL (5 patients)
MUSCULOSKELETAL PAIN (5 patients)
GASTRIC ULCER (5 patients)
HEPATOTOXICITY (5 patients)
INCORRECT DOSE ADMINISTERED (5 patients)
DYSGEUSIA (4 patients)
SPEECH DISORDER (4 patients)
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED (4 patients)
VENTRICULAR EXTRASYSTOLES (4 patients)
AFFECT LABILITY (4 patients)
HAEMATOCRIT DECREASED (4 patients)
RESPIRATORY FAILURE (4 patients)
HYPERPARATHYROIDISM SECONDARY (4 patients)
LOSS OF CONSCIOUSNESS (4 patients)
MULTIPLE EPIPHYSEAL DYSPLASIA (4 patients)
ANXIETY (4 patients)
OFF LABEL USE (4 patients)
HEART RATE INCREASED (4 patients)
ASTHMA (4 patients)
ATELECTASIS (4 patients)
EPILEPSY (4 patients)
NEPHROGENIC SYSTEMIC FIBROSIS (4 patients)
BLOOD CREATININE INCREASED (4 patients)
RASH GENERALISED (4 patients)
RESPIRATORY DISORDER (4 patients)
RESPIRATORY DISTRESS (4 patients)
BONE MARROW FAILURE (4 patients)
SUPRAVENTRICULAR EXTRASYSTOLES (4 patients)
BREAST CANCER METASTATIC (4 patients)
VERTIGO (4 patients)
VIRAL INFECTION (4 patients)
LABORATORY TEST ABNORMAL (4 patients)
LIVER FUNCTION TEST ABNORMAL (4 patients)
CARDIOGENIC SHOCK (4 patients)
FALL (4 patients)
FEELING ABNORMAL (4 patients)
FLUSHING (4 patients)
NEPHROLITHIASIS (4 patients)
NEUROPATHY PERIPHERAL (4 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (4 patients)
GRANULOMA (4 patients)
COLON CANCER (4 patients)
PARAESTHESIA (4 patients)
PNEUMONIA BACTERIAL (4 patients)
CONDITION AGGRAVATED (4 patients)
HYPERBILIRUBINAEMIA (4 patients)
COUGH (4 patients)
DELUSION (4 patients)
INFECTION (4 patients)
SINUS BRADYCARDIA (4 patients)
TREMOR (4 patients)
DISEASE PROGRESSION (4 patients)
INTERSTITIAL LUNG DISEASE (4 patients)
UNEVALUABLE EVENT (4 patients)
ABDOMINAL PAIN UPPER (3 patients)
ABNORMAL BEHAVIOUR (3 patients)
DYSPHONIA (3 patients)
PROPHYLAXIS OF NAUSEA AND VOMITING (3 patients)
ECONOMIC PROBLEM (3 patients)
NON-NEUTRALISING ANTIBODIES POSITIVE (3 patients)
MULTI-ORGAN FAILURE (3 patients)
ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE (3 patients)
FEMUR FRACTURE (3 patients)
PLEURAL EFFUSION (3 patients)
PELVIC PAIN (3 patients)
RESTLESSNESS (3 patients)
SCIATICA (3 patients)
SYNCOPE (3 patients)
MELAENA (3 patients)
ESCHERICHIA INFECTION (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
BLOOD CHOLESTEROL INCREASED (3 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (3 patients)
GASTROINTESTINAL MOTILITY DISORDER (3 patients)
BLOOD GLUCOSE INCREASED (3 patients)
BLOOD HOMOCYSTEINE INCREASED (3 patients)
RASH (3 patients)
PSYCHOMOTOR HYPERACTIVITY (3 patients)
BLOOD UREA INCREASED (3 patients)
IMPETIGO (3 patients)
INCOHERENT (3 patients)
TACHYPNOEA (3 patients)
TUMOUR NECROSIS (3 patients)
LEUKOCYTOSIS (3 patients)
CARDIAC ARREST (3 patients)
CARDIAC DISORDER (3 patients)
MELAS SYNDROME (3 patients)
METABOLIC ACIDOSIS (3 patients)
ELECTROENCEPHALOGRAM ABNORMAL (3 patients)
EMOTIONAL DISTRESS (3 patients)
ENCEPHALOMALACIA (3 patients)
EPISTAXIS (3 patients)
ERYTHEMA (3 patients)
CEREBRAL INFARCTION (3 patients)
NASOPHARYNGITIS (3 patients)
HAEMATEMESIS (3 patients)
OSTEOPOROSIS (3 patients)
COMMUNICATION DISORDER (3 patients)
PLEURAL FIBROSIS (3 patients)
PULMONARY CONGESTION (3 patients)
CONGESTIVE CARDIOMYOPATHY (3 patients)
HALLUCINATION, VISUAL (3 patients)
HYPERAMMONAEMIA (3 patients)
RECTAL HAEMORRHAGE (3 patients)
CRYPTOGENIC ORGANIZING PNEUMONIA (3 patients)
RENAL DISORDER (3 patients)
HYPOAESTHESIA (3 patients)
DELIRIUM (3 patients)
RETCHING (3 patients)
TACHYCARDIA (3 patients)
TRANSPLANT REJECTION (3 patients)
SKIN DISCOLOURATION (3 patients)
IRRITABLE BOWEL SYNDROME (3 patients)
DRY SKIN (3 patients)
JOINT STIFFNESS (3 patients)
DYSARTHRIA (3 patients)
ANORECTAL DISCOMFORT (2 patients)
LUNG INFECTION (2 patients)
MEDICAL DEVICE DISCOMFORT (2 patients)
MELANOSIS COLI (2 patients)
WRONG TECHNIQUE IN DRUG USAGE PROCESS (2 patients)
CARDIAC FAILURE ACUTE (2 patients)
MEDICATION ERROR (2 patients)
CARDIAC MURMUR (2 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for L-CARNITINE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about HALLUCINATION, AUDITORY and L-CARNITINE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking L-CARNITINE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in L-CARNITINE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for L-CARNITINE experts. If you are a healthcare provider experienced in prescribing L-CARNITINE, please register here.
© 2014 FactMed, Inc
Privacy Policy
Terms of Use